Correction to Integral Diagnostics Rating on August 10
Dow Jones2026/08/12 14:37"*Intergral Diagnostics Target Price Cut 5.3% to A$3.60/Share by Bell Potter>IDX.AU," published at 6:59 p.m. ET on August 10, 2026 misspelled the company name. It is Integral Diagnostics Ltd.
(END) Dow Jones Newswires
August 12, 2026 10:37 ET (14:37 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Is the Federal Reserve repeating the 2022-style rate hikes? Bank of America warns: Rates may return above 5%, suggests shorting two-year U.S. Treasuries.
Bank of America warns: With Waller at the helm, the Federal Reserve may raise interest rates above 5%, potentially repeating the events of 2022.
OpenAI is expected to burn over $278 billion in cash by 2030, with a revenue target of $350 billion over the same period.
OpenAI is expected to generate up to $278 billion in negative free cash flow over the next five years, driven solely by computing power and infrastructure, with cumulative spending projected to reach approximately $856 billion by 2030. The company anticipates revenue of $350 billion in 2030 and $36 billion in 2026, with total revenue from 2026 to 2030 amounting to around $840 billion.
Garrett Jin's ZEC short position has an unrealized loss of $33.422 million.
Crypto prices
More
